Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Cancer MedicineOpen Access

Anticipated Out‐Of‐Pocket Costs and Prostate Cancer Management Among Men With Commercial Insurance

View Full Paper
Ask AI
Bookmark
Share

Authors

SLSarah LeickASAddison ShaySKSamuel R. Kaufman

Discussion

Loading...

Member takes

Overview

Analysis identifies out-of-pocket costs influencing treatment choices for prostate cancer, suggesting management strategy insensitivity.

Key Points

  • Anticipated out-of-pocket costs for men with prostate cancer vary significantly, yet treatment choice remains largely unaffected.
  • Among 58,206 men with prostate cancer, approximately 12% faced no anticipated out-of-pocket costs, while the median for others was $350.
  • Adjust adjusted percentages for immediate treatment ranged narrowly from 77.8% to 78.6% across cost quartiles.
  • Logistic regression was employed to assess the relationship between predicted costs and management decisions among men with prostate cancer.

Cite This Study

Leick et al. (2025) studied this question.

synapsesocial.com/papers/68c1d60654b1d3bfb60f9779https://doi.org/10.1002/cam4.71184
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Out‐of‐pocket costs for diagnostic testing following abnormal prostate cancer screening among privately insured men2024 · 4 citations
  2. 2The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis2024 · 1 citations
  3. 3MP57-02 OUT-OF-POCKET COSTS DOWNSTREAM OF PROSTATE CANCER SCREENING AMONG PRIVATELY INSURED MEN2024
  4. 4Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs2024
  5. 5Estimating cost of prostate cancer management: an experience from Tanzania2024 · 2 citations